article thumbnail

Healthcare AI Bias: Reasons and Resolutions

Healthcare IT Today

The following is a guest article by Anand Shroff, President at Verantos.

article thumbnail

How Happy Cells Manufacture New Medications

Healthcare IT Today

The development and manufacturing process for these important new drugs is very different from traditional medicines. This article focuses on the technology that ensures quality in the process, and is based on a conversation with Graziella Piras, PhD, Life Science Business Development Director at 908 Devices.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Three Ways AI, If Trusted, Can Transform the Healthcare Landscape

Healthcare IT Today

We’re already seeing the benefits of AI-infused research in pharmaceuticals and drug development. According to WEF , the largest ten pharmaceutical companies have either partnered with or acquired AI companies to make use of AI-assisted drug development and design.

article thumbnail

Weekly Roundup – October 1, 2022

Healthcare IT Today

Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. In this video, R-Zero Systems CEO and Co-Founder Grant Morgan explores use cases for UV technology in healthcare for COVID and beyond.

eHealth 84
article thumbnail

Bonus Features – August 7, 2022 – Patients like digital health but have security concerns, healthcare leaders optimistic “seamless” care is coming, and more

Healthcare IT Today

Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Please include any relevant links and let us know if news is under embargo.

eCare 80
article thumbnail

How Technology Can Help Overcome Barriers to Getting Effective Therapies into Patients with Ultra Rare Disorders

Healthcare IT Today

The following is a guest article by Dr. Zach Landman, Co-Founder of Moonshots for Unicorns. As we saw with COVID, when treatments were needed more rapidly than the typical drug development timeline could offer, we identified existing medicines that could be repurposed (such as remdesevir and dexamethasone, among many others.)

article thumbnail

Bonus Features – June 26, 2022 – Walgreens gets into clinical trials, ONC offering SDOH grants, and more

Healthcare IT Today

Welcome to the inaugural edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. The Office of the National Coordinator for Health IT has some money for you.